{
  "main_header": {
    "sid": 294056,
    "name": "Lincoln Pharma.",
    "stock_name": "Lincoln Pharma.",
    "full_name": "Lincoln Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/lincoln-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "484.15",
    "chg": -6.3,
    "chgp": "-1.28%",
    "dir": -1,
    "prev_price": "490.45",
    "mcapval": "933.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531633,
    "symbol": "LINCOLN",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE405C01035",
    "curr_date": "Dec 24",
    "curr_time": "",
    "bse_nse_vol": "24.64 k",
    "exc_status": "Active",
    "traded_date": "Dec 24, 2025",
    "traded_date_str": "2025 12 24",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lincoln-pharma-294056-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Lincoln Pharmaceuticals Stock Falls to 52-Week Low of Rs.466",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-stock-hits-52-week-low-at-rs466-3767961",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/LincolnPharmace_priceRelatedfactors_3767961.png",
        "date": "2025-12-24 09:42:54",
        "description": "Lincoln Pharmaceuticals has reached a new 52-week low, with its stock price touching Rs.466 today. This marks a significant decline amid broader market gains, as the stock underperformed its sector and reversed a short-term upward trend."
      },
      {
        "title": "Lincoln Pharma. Sees Revision in Market Evaluation Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lincoln-pharma-upgraded-from-strong-sell-to-sell-by-marketsmojo-on-5-aug-2025-3764782",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/LincolnPharma_mojoScore_3764782.png",
        "date": "2025-12-21 10:10:24",
        "description": "Lincoln Pharma., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting nuanced shifts across key analytical parameters. This development comes amid a backdrop of subdued financial performance and challenging market conditions."
      },
      {
        "title": "Lincoln Pharmaceuticals Stock Falls to 52-Week Low of Rs.466.4",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-stock-falls-to-52-week-low-of-rs4664-3758603",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/LincolnPharmace_priceRelatedfactors_3758603.png",
        "date": "2025-12-15 10:08:18",
        "description": "Lincoln Pharmaceuticals has touched a new 52-week low of Rs.466.4, marking a significant decline in its stock price amid broader market movements and company-specific performance trends."
      },
      {
        "title": "Why is Lincoln Pharma. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-lincoln-pharma-fallingrising-3756732",
        "imagepath": "",
        "date": "2025-12-12 00:44:15",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Extended Underperformance Against Benchmarks</strong></p>\n<p>Lincoln Pharmaceuticals has been struggling to maintain momentum relative to the Sensex and its sector peers. Over the past week, the stock has declined by 4.76%, significantly underperforming the Sensex’s modest 0.52% fall. The one-month performance is even more stark, with the stock shedding 9.78% while the Sensex gained 1.13%. Year-to-date, the stock has plunged 40.23%, contrasting sharply with the Sensex’s 8.55% rise. Over the last year, Lincoln Pharma’s shares have halved, falling 50.02%, whereas the Sensex has managed a 4.04% gain. These figures underscore a persistent weakness in the stock’s price action, signalling challenges that have yet to be resolved.</p>\n<p><strong>Technical Indicators and Price Levels Signal Continued..."
      },
      {
        "title": "Lincoln Pharmaceuticals Stock Falls to 52-Week Low of Rs.470.15",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-stock-hits-52-week-low-amidst-continued-downtrend-3753444",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/LincolnPharmace_priceRelatedfactors_3753444.png",
        "date": "2025-12-09 09:58:00",
        "description": "Lincoln Pharmaceuticals has reached a new 52-week low of Rs.470.15, marking a significant decline amid a broader market downturn. The stock has experienced a sustained downward trend over the past four days, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Lincoln Pharmaceuticals Stock Falls to 52-Week Low of Rs.481",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-stock-falls-to-52-week-low-of-rs481-3750766",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/LincolnPharmace_priceRelatedfactors_3750766.png",
        "date": "2025-12-08 09:56:15",
        "description": "Lincoln Pharmaceuticals has reached a new 52-week low of Rs.481, marking a significant decline in its stock price amid a broader market environment where the Sensex has shown mixed signals. The stock’s recent performance reflects ongoing pressures within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Lincoln Pharmaceuticals Stock Falls to 52-Week Low of Rs.481",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-stock-falls-to-52-week-low-of-rs481-3750772",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/LincolnPharmace_priceRelatedfactors_3750772.png",
        "date": "2025-12-08 09:55:52",
        "description": "Lincoln Pharmaceuticals has reached a new 52-week low of Rs.481, marking a significant decline in its stock price amid a broader market environment where the Sensex trades near its yearly highs. The stock has experienced a three-day consecutive fall, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Lincoln Pharma. Sees Revision in Market Evaluation Amidst Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lincoln-pharma-upgraded-from-strong-sell-to-sell-by-marketsmojo-3737093",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/LincolnPharma_mojoScore_3737093.png",
        "date": "2025-11-30 10:24:43",
        "description": "Lincoln Pharma., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting nuanced shifts across key analytical parameters. This development comes amid a backdrop of subdued financial performance and challenging market conditions, prompting a reassessment of the company’s standing within its sector."
      },
      {
        "title": "Lincoln Pharmaceuticals Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-technical-momentum-shifts-amid-bearish-signals-3719579",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/LincolnPharmace_technicaldot_3719579.png",
        "date": "2025-11-21 08:02:34",
        "description": "Lincoln Pharmaceuticals has experienced a notable shift in its technical momentum, reflecting a complex interplay of market forces and indicator signals. Recent evaluation adjustments reveal a transition from mildly bearish to bearish technical trends, underscoring a nuanced market assessment for this Pharmaceuticals & Biotechnology sector stock."
      }
    ],
    "total": 930,
    "sid": "294056",
    "stock_news_url": "https://www.marketsmojo.com/news/lincoln-pharmaceuticals-294056"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "14-Nov-2025",
      "details": "Pursuant to Regulation 47 of SEBI (LODR) Regulations 2015 we enclosed herewith the copies of newspaper intimation with respect to un-audited financial results for the quarter and half year ended on 30.09.2025.",
      "source": "BSE"
    },
    {
      "caption": "UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED ON 30.09.2025",
      "datetime": "13-Nov-2025",
      "details": "UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED ON 30.09.2025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED ON 30.09.2025",
      "datetime": "13-Nov-2025",
      "details": "UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED ON 30.09.2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Lincoln Pharmaceuticals Ltd has declared <strong>18%</strong> dividend, ex-date: 12 Sep 25",
          "dt": "2025-09-12",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Lincoln Pharmaceuticals Ltd has announced <strong>10:2</strong> stock split, ex-date: 19 Mar 09",
          "dt": "2009-03-19",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Lincoln Pharmaceuticals Stock Falls to 52-Week Low of Rs.466

2025-12-24 09:42:54

Lincoln Pharmaceuticals has reached a new 52-week low, with its stock price touching Rs.466 today. This marks a significant decline amid broader market gains, as the stock underperformed its sector and reversed a short-term upward trend.

Read More

Lincoln Pharma. Sees Revision in Market Evaluation Amid Mixed Financial Signals

2025-12-21 10:10:24

Lincoln Pharma., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting nuanced shifts across key analytical parameters. This development comes amid a backdrop of subdued financial performance and challenging market conditions.

Read More

Lincoln Pharmaceuticals Stock Falls to 52-Week Low of Rs.466.4

2025-12-15 10:08:18

Lincoln Pharmaceuticals has touched a new 52-week low of Rs.466.4, marking a significant decline in its stock price amid broader market movements and company-specific performance trends.

Read More

Why is Lincoln Pharma. falling/rising?

2025-12-12 00:44:15

Extended Underperformance Against Benchmarks

Lincoln Pharmaceuticals has been struggling to maintain momentum relative to the Sensex and its sector peers. Over the past week, the stock has declined by 4.76%, significantly underperforming the Sensex’s modest 0.52% fall. The one-month performance is even more stark, with the stock shedding 9.78% while the Sensex gained 1.13%. Year-to-date, the stock has plunged 40.23%, contrasting sharply with the Sensex’s 8.55% rise. Over the last year, Lincoln Pharma’s shares have halved, falling 50.02%, whereas the Sensex has managed a 4.04% gain. These figures underscore a persistent weakness in the stock’s price action, signalling challenges that have yet to be resolved.

Technical Indicators and Price Levels Signal Continued...

Read More

Lincoln Pharmaceuticals Stock Falls to 52-Week Low of Rs.470.15

2025-12-09 09:58:00

Lincoln Pharmaceuticals has reached a new 52-week low of Rs.470.15, marking a significant decline amid a broader market downturn. The stock has experienced a sustained downward trend over the past four days, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.

Read More

Lincoln Pharmaceuticals Stock Falls to 52-Week Low of Rs.481

2025-12-08 09:56:15

Lincoln Pharmaceuticals has reached a new 52-week low of Rs.481, marking a significant decline in its stock price amid a broader market environment where the Sensex has shown mixed signals. The stock’s recent performance reflects ongoing pressures within the Pharmaceuticals & Biotechnology sector.

Read More

Lincoln Pharmaceuticals Stock Falls to 52-Week Low of Rs.481

2025-12-08 09:55:52

Lincoln Pharmaceuticals has reached a new 52-week low of Rs.481, marking a significant decline in its stock price amid a broader market environment where the Sensex trades near its yearly highs. The stock has experienced a three-day consecutive fall, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.

Read More

Lincoln Pharma. Sees Revision in Market Evaluation Amidst Mixed Financial Signals

2025-11-30 10:24:43

Lincoln Pharma., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting nuanced shifts across key analytical parameters. This development comes amid a backdrop of subdued financial performance and challenging market conditions, prompting a reassessment of the company’s standing within its sector.

Read More

Lincoln Pharmaceuticals Technical Momentum Shifts Amid Mixed Market Signals

2025-11-21 08:02:34

Lincoln Pharmaceuticals has experienced a notable shift in its technical momentum, reflecting a complex interplay of market forces and indicator signals. Recent evaluation adjustments reveal a transition from mildly bearish to bearish technical trends, underscoring a nuanced market assessment for this Pharmaceuticals & Biotechnology sector stock.

Read More

View All News